Cardio-protective effect of statins in patients with HER2 positive breast cancer receiving trastuzumab therapy
ConclusionsIn women with HER2+ breast cancer receiving trastuzumab-based therapy with or without anthracyclines, concomitant statin use was associated with a lower risk of cardiotoxicity.
Source: Canadian Journal of Cardiology - Category: Cardiology Source Type: research
More News: Breast Cancer | Canada Health | Cancer | Cancer & Oncology | Cardiology | Cholesterol | Diabetes | Endocrinology | Heart | HER2 | Herceptin | Hypertension | Statin Therapy | Women